CROI 2016 Program at a Glance

Program and Agenda

604 Liver Cancer After Hep C Cure: Less Cirrhosis and Less Liver Fat Than Expected Andrea Branch ; Chiara Rocha; M. I. Fiel; Erin Doyle; Nicholas Goosens; Yujin Hoshida;Thomas Schiano; Myron Schwartz IcahnSchofMedatMountSinai,NewYork,NY,USA 605 Residual Risk of Disease Progression After Hepatitis C Cure in HIV-HCV Patients Dominique Salmon-Ceron 1 ; Camille Gilbert 2 ; Philippe Sogni 1 ; Francois Dabis 3 ; Julie Bottero 4 ; Patrick Miailhes 5 ; Lionel Piroth 6 ; Firouzé Bani-Sadr 7 ; LindaWittkop 8 ; for the the ANRS CO13 Hepavih Study Group 1 INSERM-APHP,HospCochin,Paris,France; 2 INSERM,Bordeaux,France; 3 INSERMU897, ISPED,UnivdeBordeaux,Bordeaux,France; 4 Hôpitauxde Paris,HôpitauxUniversitairesParis-Sud,LeKremlin-Bicêtre,France; 5 CHU Lyon,Lyon,France; 6 CHUDijon,Dijon,France; 7 CHUReims,Reims,France; 8 CHUdeBordeaux,Bordeaux,France 606 Hepatitis C Genotype 6 Is AssociatedWith Progression of Liver Fibrosis in HIV Patients Anchalee Avihingsanon 1 ; Suparat Khemnark 2 ;Tanakorn Apornpong 1 ; Sivaporn Kukanok 1 ;Vorapot Sapsirisavat 1 ; Salyavit Chittmittrapap 2 ; Stephen J. Kerr 1 ; SombatTreeprasertsuk 2 ; Pisit Tankijvanich 2 ; Kiat Ruxrungtham 1 ; for the HCV StudyTeam 1 HIV-NAT,ThaiRedCrossAIDSRsrCntr,Bangkok,Thailand; 2 ChulalongkornUniv,Bangkok,Thailand 607 Impact of Occult HBV Infection in HCC Presentation in HCV-Related Cirrhosis 2:45 PM-4:00 PM HCV Mischief From Beyond the Liver 608 CB2-63 RR Variant Is AssociatedWith Immune- Mediated Disorders in HCV Patients Nicola Coppola ; Rosa Zampino; Giulia Bellini; Maria Stanzione; Nicolina Capoluongo; Margherita Macera; Luigi E. Adinolfi; Emanuele Miraglia Del Giudice; Evangelista Sagnelli; Francesca Rossi SecondUnivofNaples,Naples, Italy 609 Prevalence and Risk Factors of LowMuscle Mass in HIV/ Viral Hepatitis Coinfection Charitha Gowda 1 ;ToddT. Brown 2 ; Charlene Compher 1 ; Kimberly A. Forde 1 ; Jay R. Kostman 3 ; Pamela A. Shaw 4 ; PhyllisTien 5 ;Vincent Lo Re 1 1 UnivofPennsylvania,Philadelphia,PA,USA; 2 JohnsHopkinsUniv, Baltimore,MD,USA; 3 JohnBellHlthCntr,Philadelphia,PA,USA; 4 Univof Pennsylvania,Phialdelphia,PA,USA; 5 UnivofCaliforniaSanFrancisco, SanFrancisco,CA,USA 610 Rapid Improving of Glycemic Control in HCV Patients TreatedWith IFN-Free Regimens Nicola Coppola 1 ;Valentina Lodice 2 ; Mario Starace 1 ; Carmine Minichini 1 ; Nunzia Farella 2 ; Lorenzo Onorato 1 ; Giulia Liorre 2 ; Evangelista Sagnelli 1 ; Giorgio De Stefano 2 1 SecondUnivofNaples,Naples, Italy; 2 AORNdeiColli,P.O.Cotugno, Naples, Italy Session P-N12 Poster Abstracts Hall A/B

611 Eradication of HCV and Extrahepatic Comorbidities in HIV/HCV Coinfection Juan Berenguer 1 ; Miguel A.VonWichmann 2 ; José López-Aldeguer 3 ; María J. Galindo 4 ; Josep Mallolas 5 ; Manel Crespo 6 ; María J.Tellez 7 ; José M. Bellón 1 ; Juan González-García 8 ; for the GeSIDA 3603 Study Group 1 HospGeneralUniversitarioGregorioMarañón,Madrid,Spain; 2 Hosp UniversitarioDonostia,SanSebastián,Spain; 3 HospUniversitari i PolitècnicLaFe,Valencia,Spain; 4 HospClínicoUniversitariodeValencia, Valencia,Spain; 5 HospClínicdeBarcelona,Barcelona,Spain; 6 Hosp UniversitariValld Hebron,Barcelona,Spain; 7 HospClinicoSanCarlos, Madrid,Spain; 8 Inst forHlthRsrofLaPazUnivHosp,Madrid,Spain 612 Hepatitis C and the Risk of Non-Liver-Related Morbidity and Mortality in HIV+ Persons Helen Kovari 1 ; RainerWeber 1 ; Alexandra L. Calmy 2 ; Matthias Cavassini 3 ; Marcel Stoeckle 4 ; Patrick Schmid 5 ; Enos Bernasconi 6 ; Andri Rauch 7 ; Bruno Ledergerber 1 ; for the Swiss HIV Cohort Study 1 UnivHospZurich,Zurich,Switzerland; 2 UnivHospGeneva,Univof Geneva,Geneva,Switzerland; 3 UnivHospLausanne,UnivofLausanne, Lausanne,Switzerland; 4 UnivHospBasel,Basel,Switzerland; 5 Cantonal Hosp,StGall,Switzerland,StGall,Switzerland; 6 RegionalHosp Lugano,Lugano,Switzerland; 7 BernUnivHospandUnivofBern,Bern, Switzerland 2:45 PM-4:00 PM Lymphoma and Kaposi Sarcoma 629 APOBEC3 Boosters Kill Primary Effusion Lymphoma and Other Cancer Cell Lines Chisu Song 1 ; Gary Schiltz 2 ; Meejeon Roh 1 ; Isabelle Clerc 1 ; Neha Malik 2 ; Hannah Hudson 1 ; Kiwon Nam 2 ; RichardT. D’Aquila 1 1 NorthwesternUniv,FeinbergSchofMed,Chicago, IL,USA; 2 NorthwesternUniv,Chicago, IL,USA 630 Risk Factors for Hodgkin (HL) and Non-Hodgkin Lymphoma (NHL) in Europe Copenhagen,Copenhagen,Denmark; 3 MedizinischePoliklinik,Munich, Germany; 4 Hosp for InfectiousDiseases inWarsaw,MedUnivofWarsaw, Warsaw,Poland; 5 AcademicianBlokhinaNizhnyNovgorodRsr Instof EpiandMicrobiology,Novgorod,RussianFederation; 6 UnivHospBasel, Basel,Switzerland; 7 Hosp J.M.RamosMejia,BuenosAires,Argentina; 8 RigsHospet,UnivofCopenhagen,Copenhagen,Denmark 631 Kaposi Sarcoma Survival in Adults: The South African Antiretroviral Treatment Era Mazvita M. Sengayi 1 ; Danuta M. Kielkowski 1 ; Matthias Egger 2 ; Lydia Dreosti 3 ; Julia Bohlius 4 1 NatlCancerRegistry,NHLS, Johannesburg,SouthAfrica; 2 UnivHosp Bern,Bern,Switzerland; 3 UnivofPretoriaandSteveBikoAcademicHosp, Pretoria,SouthAfrica; 4 InstofSocialandPreventiveMed,UnivofBern, Bern,Switzerland Session P-O3 Poster Abstracts Leah Shepherd 1 ; Alvaro H. Borges 2 ; Johannes Bogner 3 ; Andrzej Horban 4 ; Elena Kuzovatova 5 ; Manuel Battegay 6 ; Marcelo Losso 7 ; Jens D. Lundgren 8 ; Amanda Mocroft 1 ; for the EuroSIDA in EuroCOORD 1 UnivCollLondon,London,UK; 2 CHIP,Rigshospitalet,Univof Hall A/B

Poster Listings

Paolo Pavone ;TizianaTieghi; Gabriella D’Ettorre; Miriam Lichtner; Raffaella Marocco; Ivano Mezzaroma; Giulia Passavanti; Claudio M. Mastroianni;VincenzoVullo SapienzaUnivofRome,Rome, Italy

CROI 2016 114